Cyclophosphamide treatment of diabetes insipidus in Wegener's granulomatosis. 1979

A Pont, and L Y Yamaguchi, and M G DeLada

UI MeSH Term Description Entries
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003919 Diabetes Insipidus A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014890 Granulomatosis with Polyangiitis A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN. Granulomatosis, Wegener's,Wegener Granulomatosis,Wegener's Granulomatosis,Granulomatosis with Polyangiitides,Granulomatosis, Wegener,Polyangiitides, Granulomatosis with,Polyangiitis, Granulomatosis with,with Polyangiitides, Granulomatosis,with Polyangiitis, Granulomatosis

Related Publications

A Pont, and L Y Yamaguchi, and M G DeLada
October 1978, The New England journal of medicine,
A Pont, and L Y Yamaguchi, and M G DeLada
August 1982, Fortschritte der Medizin,
A Pont, and L Y Yamaguchi, and M G DeLada
July 1999, Rheumatology (Oxford, England),
A Pont, and L Y Yamaguchi, and M G DeLada
March 2006, Ugeskrift for laeger,
A Pont, and L Y Yamaguchi, and M G DeLada
October 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
A Pont, and L Y Yamaguchi, and M G DeLada
October 1983, Annals of the rheumatic diseases,
A Pont, and L Y Yamaguchi, and M G DeLada
February 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Pont, and L Y Yamaguchi, and M G DeLada
January 1993, Advances in experimental medicine and biology,
A Pont, and L Y Yamaguchi, and M G DeLada
April 1971, The New England journal of medicine,
A Pont, and L Y Yamaguchi, and M G DeLada
June 2004, AJR. American journal of roentgenology,
Copied contents to your clipboard!